Sands Capital Alternatives LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Sands Capital Alternatives LLC
CRD #155517
SEC #801-72115
CIK #0001846444
AUM 5,405.4 M (2026-03-30)
Employees 182 (36% Investors, 0% Brokers)
Phone703-562-4000
Address1000 Wilson Boulevard
Arlington, VA 22209
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($B)
6.04.83.62.41.20.02010201520212027
Sector Form 13F Holdings Value ($B)
Nvidia Corp 3.2
Taiwan Semiconductor Manufacturing Co Ltd 2.0
Alphabet Inc 1.5
Amazon Com Inc 1.4
Shopify Inc 1.1
Netflix Inc 0.9
Spotify Technology Sa 0.9
ASML Holding NV 0.8
Visa Inc 0.8
MercadoLibre Inc 0.8
View All
Holdings by Sector ($B)
1108866442202011201620212027
Type Form D Funds Date Sold AUM
PE Sands Capital Global Innovation Fund II-FG LP [2026-03-30] 7.0 M
Filed 2025-04-30 (D) · Exemption 506(c), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Sands Capital Global Innovation Fund III-2 LP [2026-03-30] 556.4 M
Filed 2025-05-19 (D) · Exemption 506(c), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Sands Capital Global Innovation Fund III LP [2026-03-30] 973.5 M 164.9 M
Filed 2026-01-28 (D/A) · Exemption 506(c), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
PE Sands Capital Global Innovation Fund III-RP LP [2026-03-30] 20.0 M 62.9 M
Filed 2025-05-02 (D) · Exemption 506(c), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Sands Capital Global Innovation Fund III-X LP [2026-03-30] 163.2 M
Filed 2025-05-19 (D) · Exemption 506(c), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Sands Capital Global Innovation Fund II-An LP [2025-03-31] 119.4 M
Filed 2024-06-25 (D) · Exemption 506(c), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Sands Capital Global Innovation Fund II-DB LP [2025-03-31] 154.9 M
Filed 2024-12-12 (D) · Exemption 506(c), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
VC Sands Capital Global Venture Fund II-Pa LP [2025-03-31] 4.4 M
Filed 2024-03-27 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
VC Sands Capital Global Venture Fund II-SLX LP [2025-03-31]
Filed 2024-03-27 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Sands Capital Global Innovation Fund II-X LP 2024-03-27 62.5 M
VC Sands Capital Global Venture Fund III-SFR LP 2024-03-27 30.6 M
PE Sands Capital Life Sciences Pulse Fund III de LP 2024-03-27 11.3 M
PE Sands Capital Life Sciences Pulse Fund III LP 2024-03-27 54.9 M
VC Sands Capital Global Venture Fund I-Upg LP [2023-03-31] 4.2 M
Filed 2021-12-06 (D) · Exemption 506(c), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Sands Capital Global Innovation Fund II-GST LP [2022-03-31] 17.5 M
Filed 2021-09-15 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Sands Capital Global Innovation Fund II-KLV LP [2022-03-31] 25.0 M
Filed 2021-06-11 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Sands Capital Global Innovation Fund II LP [2022-03-31] 1,185.4 M
Filed 2021-04-12 (D) · Exemption 506(c), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
VC Sands Capital Global Venture Fund III LP [2022-03-31] 201.5 M 218.1 M
Filed 2022-08-22 (D/A) · Exemption 506(c), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
PE Sands Capital Life Sciences Pulse Fund II LP [2022-03-31] 413.4 M
Filed 2021-08-03 (D) · Exemption 506(c), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Sands Capital Global Innovation Fund Byjus LP [2021-03-29] 43.5 M 0.0 M
Offered $43,500,000 · Filed 2020-09-15 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose
PE Sands Capital Global Innovation Fund-SMS LP [2021-03-29] 7.6 M 7.6 M
Offered $7,619,744 · Filed 2020-06-17 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose
PE Sands Capital Global Innovation Fund-SX LP [2021-03-29] 15.1 M 15.0 M
Filed 2021-12-23 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
PE Sands Capital-DR Fund LP [2020-03-30] 111.2 M 5.0 M
Filed 2020-07-07 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
PE Sands Capital Global Innovation Fund C-1 LP [2020-03-30] 29.2 M 45.3 M
Filed 2020-07-07 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
PE Sands Capital Global Innovation Fund C-1-X LP 2020-03-30 8.7 M
PE Sands Capital Global Innovation Fund LP [2020-03-30] 111.2 M 46.5 M
Filed 2020-07-07 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
PE Sands Capital Global Innovation Fund-Uip LP [2020-03-30] 10.1 M 2.9 M
Filed 2019-10-11 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Sands Capital Global Innovation Fund-X LP 2020-03-30 9.0 M
PE Sands Capital Life Sciences Pulse Fund C-1 LP [2020-03-30] 23.2 M 15.5 M
Filed 2019-07-03 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
PE Sands Capital Life Sciences Pulse Fund LP [2020-03-30] 90.5 M 31.8 M
Filed 2020-07-07 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
VC Sands Capital Global Venture Fund II LP [2019-03-29] 121.6 M 126.0 M
Filed 2018-07-17 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
VC Sands Capital Private Growth Fund-FC LP [2019-03-29] 12.0 M 13.8 M
Offered $13,751,246 · Filed 2015-05-18 (D) · Exemption 506(b), 3(c), 3(c)(1) · Remaining $1,785,759 · Duration One year or less · Revenue Decline to Disclose
VC Sands Capital Private Growth Fund-HC LP [2019-03-29] 3.7 M 5.0 M
Offered $5,000,014 · Filed 2015-05-18 (D) · Exemption 506(b), 3(c), 3(c)(1) · Remaining $1,324,629 · Duration One year or less · Revenue Decline to Disclose
VC Sands Capital Private Growth Fund II-BLBK LP [2019-03-29] 2.6 M
Offered $2,585,051 · Filed 2018-01-09 (D) · Exemption 506(b), 3(c), 3(c)(1) · Duration One year or less · Revenue Decline to Disclose
VC Sands Capital Private Growth Fund III-DC LP [2019-03-29] 5.1 M 4.4 M
Offered $5,100,000 · Filed 2019-01-11 (D) · Exemption 506(b), 3(c), 3(c)(1) · Duration One year or less · Revenue Decline to Disclose
VC Sands Capital Private Growth Fund II-MB LP [2019-03-29] 5.0 M 5.0 M
Offered $5,033,419 · Filed 2016-06-30 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose
VC Sands Capital Private Growth Fund II-UH LP [2019-03-29] 5.0 M 5.5 M
Offered $5,005,671 · Filed 2018-03-22 (D) · Exemption 506(b), 3(c), 3(c)(1) · Duration One year or less · Revenue Decline to Disclose
VC Sands Capital Private Growth Fund-MM LP [2019-03-29] 6.1 M 0.0 M
Offered $7,509,339 · Filed 2015-09-14 (D) · Exemption 506(b), 3(c), 3(c)(1) · Remaining $1,363,431 · Duration One year or less · Revenue Decline to Disclose
VC Sands Capital Ventures Fund-SLK LP [2019-03-29] 4.5 M 4.5 M
Offered $4,482,998 · Filed 2018-11-13 (D) · Exemption 506(b), 3(c), 3(c)(1) · Duration One year or less · Revenue Decline to Disclose
VC Sands Capital Private Growth BB Fund-2 LP [2018-03-28] 2.1 M 3.0 M
Offered $2,100,010 · Filed 2017-11-17 (D) · Exemption 506(b), 3(c), 3(c)(1) · Duration One year or less · Revenue Decline to Disclose
VC Sands Capital Private Growth Fund-HC3 LP [2018-03-28] 0.9 M 0.9 M
Offered $933,517 · Filed 2018-03-22 (D) · Exemption 506(b), 3(c), 3(c)(1) · Duration One year or less · Revenue Decline to Disclose
VC SCV-K8-1 LLC Series D [2018-03-28] 0.5 M 16.5 M
Offered $499,855 · Filed 2013-07-15 (D) · Exemption 506 · Minimum $10,000 · Duration One year or less · Revenue Decline to Disclose
VC Sands Capital Global Venture Fund I LP [2017-03-30] 90.1 M 168.2 M
Filed 2017-04-12 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
VC Sands Capital Private Growth BB Fund LP [2017-03-30] 11.2 M 22.7 M
Offered $11,208,313 · Filed 2017-01-09 (D) · Exemption 506(b), 3(c), 3(c)(1) · Duration One year or less · Revenue Decline to Disclose
VC Sands Capital Private Growth Fund-HC2 LP [2017-03-30] 2.5 M 3.8 M
Offered $2,534,152 · Filed 2016-06-30 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose
VC SCV-K8-1 LLC Series C [2016-03-17] 0.5 M 0.4 M
Offered $499,855 · Filed 2013-07-15 (D) · Exemption 506 · Minimum $10,000 · Duration One year or less · Revenue Decline to Disclose
VC Sands Capital Global Private Growth Fund I LP [2015-03-30] 77.4 M
Filed 2014-11-21 (D) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
VC SCV-B7-1 LLC [2014-03-28] 0.5 M 0.5 M
Offered $500,000 · Filed 2013-07-15 (D) · Exemption 506 · Minimum $10,000 · Duration One year or less · Revenue Decline to Disclose
VC SCV-K8-1 LLC Series B [2014-03-28] 0.5 M 10.0 M
Offered $499,855 · Filed 2013-07-15 (D) · Exemption 506 · Minimum $10,000 · Duration One year or less · Revenue Decline to Disclose
VC SCM-S72-1 LLC [2013-03-27] 1.5 M 20.8 M
Offered $1,500,000 · Filed 2013-01-17 (D) · Exemption 506 · Minimum $10,000 · Duration One year or less · Revenue Decline to Disclose
VC SCV-S7-1 LLC Series B [2013-03-27] 1.0 M
Offered $1,000,000 · Filed 2012-12-14 (D) · Exemption 506 · Minimum $10,000 · Duration One year or less · Revenue Decline to Disclose
VC SCV - FF - 1 LLC [2012-03-29] 0.3 M 0.1 M
Offered $350,000 · Filed 2013-01-17 (D) · Exemption 506 · Minimum $10,000 · Duration One year or less · Revenue Decline to Disclose
PE SCV Holdings Z-1 LLC [2012-03-29] 5.0 M 5.0 M
Offered $4,995,000 · Filed 2011-06-09 (D) · Exemption 506 · Duration One year or less · Revenue Decline to Disclose
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 34 5.2
(g) Pension and profit sharing plans 0 0.2
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 37 5.4
By Discretionary
Discretionary 37 5.4
Non-Discretionary 0 0.0
Total 37 5.4
By Non-United States Persons
Non-United States Persons 2.7
United States Persons 2.8
Total 37 5.4
Form D Directors Role # Filings # Firms 2011 - 2026
Jonathan Goodman Executive Officer 78 4
Michael Clarke Executive Officer 51 3
Michael Rubin Executive Officer 42 3
Erin Soule Executive Officer 55 2
Ian Ratcliffe Executive Officer 45 2
Barron Martin Executive Officer 22 2
Stephen Zachary Executive Officer 14 2
Michael Graninger Executive Officer 11 2
Scott Frederick Executive Officer 11 2
Job Taylor Executive Officer 4 2
View All
EDGAR Form CIK 2011 - 2026
13F-HR [0001846444]
13F-NT [0001846444]
3 [0001846444]
4 [0001846444]
SC 13G [0001846444]
Form 13D/13G Filer Form 13D/13G Subject Filed
Sands Capital Ventures LLC Klaviyo Inc [2024-02-13]
Firm Profile (Form ADV)
Discretionary AUM$0.0B
ServesInstitutional
Fund TypesPrivate Equity
LEI254900IDJSY5RN37GV63
Form 3/4/5 Subject 2011 - 2026
Sands Capital Life Sciences Pulse Fund II LP
Sands Capital Alternatives LLC
Sands Frank M
Inhibikase Therapeutics Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Inhibikase Therapeutics Inc IKT
Common Stock
2025-11-21 Buy 2,068,965 $1.45 2,999,999
Comparable Firms State AUM
Integrum Holdings LP
NY 5,485.3 M
QIC Investments No 1 PTY Ltd
5,483.3 M
Bansk Group LLC
NY 5,475.5 M
Monomoy Capital Management LP
CT 5,456.7 M
Motive Capital Management LLC
NY 5,424.8 M
Tailwind Management LP
NY 5,410.7 M
Bain Capital Insurance Solutions LP
MA 5,393.2 M
Cornell Capital LLC
NY 5,380.8 M
Cove Hill Partners LP
MA 5,355.7 M
Flexstone Partners LLC
NY 5,303.8 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com